VHL and renal carcinoma: Peruzzi et al. discovered that β-catenin is degraded by the E3-ubiquitin ligase activity of VHL and loss of VHL enables HGF-driven oncogenic β-catenin signaling as a novel target for VHL, thus implicating Wnt signaling in the pathogenesis of renal cancer [66].